These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9372614)

  • 61. Biodistribution and photodynamic efficacy of a water-soluble, stable, halogenated bacteriochlorin against melanoma.
    Dąbrowski JM; Urbanska K; Arnaut LG; Pereira MM; Abreu AR; Simões S; Stochel G
    ChemMedChem; 2011 Mar; 6(3):465-75. PubMed ID: 21265022
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tissue uptake study and photodynamic therapy of melanoma-bearing mice with a nontoxic, effective chlorin.
    Dąbrowski JM; Krzykawska M; Arnaut LG; Pereira MM; Monteiro CJ; Simões S; Urbańska K; Stochel G
    ChemMedChem; 2011 Sep; 6(9):1715-26. PubMed ID: 21732537
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Photodynamic therapy of C3H mouse mammary carcinoma with haematoporphyrin di-ethers as sensitizers.
    Evensen JF; Sommer S; Rimington C; Moan J
    Br J Cancer; 1987 May; 55(5):483-6. PubMed ID: 2955805
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetics of Ro 03-8799 in mice bearing melanosarcoma: comparison with tumors without melanin.
    Laurent F; Canal P; Soula G
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1101-3. PubMed ID: 2703390
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Correlation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma.
    Peng Q; Moan J
    Br J Cancer; 1995 Sep; 72(3):565-74. PubMed ID: 7669563
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Proposal of modified mechanisms for photodynamic therapy.
    Leupold D; Freyer W
    J Photochem Photobiol B; 1992 Feb; 12(3):311-3. PubMed ID: 1635015
    [No Abstract]   [Full Text] [Related]  

  • 67. Synthesis and photobiological study of a novel chlorin photosensitizer BCPD-18MA for photodynamic therapy.
    Zhang J; Deng L; Yao J; Gu P; Yang F; Wang X; Liu W; Zhang Y; Ke X; Jing X; Chen J
    Bioorg Med Chem; 2011 Sep; 19(18):5520-8. PubMed ID: 21855352
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Porphyrins as radiosensitizing agents for solid neoplasms.
    Schaffer M; Ertl-Wagner B; Schaffer PM; Kulka U; Hofstetter A; Dühmke E; Jori G
    Curr Pharm Des; 2003; 9(25):2024-35. PubMed ID: 14529413
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A novel ATX-S10(Na) photodynamic therapy for human skin tumors and benign hyperproliferative skin.
    Takahashi H; Itoh Y; Nakajima S; Sakata I; Iizuka H
    Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):257-65. PubMed ID: 15379877
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Autolymphocyte therapy--I. In vivo tumour-specific adoptive cellular therapy of murine melanoma and carcinoma using ex vivo activated memory T-lymphocytes.
    Gold JE; Osband ME
    Eur J Cancer; 1994; 30A(12):1871-82. PubMed ID: 7880620
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice.
    Brasseur N; Ouellet R; La Madeleine C; van Lier JE
    Br J Cancer; 1999 Jul; 80(10):1533-41. PubMed ID: 10408394
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Benzoporphyrin-lipoprotein-mediated photodestruction of intraocular tumors.
    Schmidt-Erfurth U; Flotte TJ; Gragoudas ES; Schomacker K; Birngruber R; Hasan T
    Exp Eye Res; 1996 Jan; 62(1):1-10. PubMed ID: 8674504
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Design of Pluronic-Based Formulation for Enhanced Redaporfin-Photodynamic Therapy against Pigmented Melanoma.
    Pucelik B; Arnaut LG; Stochel G; Dąbrowski JM
    ACS Appl Mater Interfaces; 2016 Aug; 8(34):22039-55. PubMed ID: 27492026
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Action spectrum of photoactivated phthalocyanine AIS2Pc in tumor bearing mice.
    Canti G; Lattuada D; Leroy E; Cubeddu R; Taroni P; Valentini G
    Anticancer Drugs; 1992 Apr; 3(2):139-42. PubMed ID: 1525391
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Meso-tetraphenylporphyrin dimer derivative as a potential photosensitizer in photodynamic therapy.
    Faustino MA; Neves MG; Vicente MG; Cavaleiro JA; Neumann M; Brauer HD; Jori G
    Photochem Photobiol; 1997 Oct; 66(4):405-12. PubMed ID: 9337611
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Assessment of the possibility of using the photodynamic effect in rheumatology].
    Tauraĭtis VA; Shishporenok SI; Grubina LA; Sarzhevskaia MV; Gurinovich IF; GGurinovich GP; Matulis AA
    Biofizika; 1992; 37(2):345-51. PubMed ID: 7578326
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MDP-Lys(L18), a lipophilic derivative of muramyl dipeptide, inhibits the metastasis of haematogenous and non-haematogenous tumours in mice.
    Yoo YC; Saiki I; Sato K; Azuma I
    Vaccine; 1994 Feb; 12(2):175-60. PubMed ID: 8147100
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Experimental photodynamic therapy with MESO-tetrakisphenylporphyrin (TPP) in liposomes leads to disintegration of human amelanotic melanoma implanted to nude mice.
    Jezek P; Nekvasil M; Skobisová E; Urbánková E; Jirsa M; Zadinová M; Poucková P; Klepácek I
    Int J Cancer; 2003 Feb; 103(5):693-702. PubMed ID: 12494481
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Human pancreatic carcinoma cells are sensitive to photodynamic therapy in vitro and in vivo.
    Hajri A; Coffy S; Vallat F; Evrard S; Marescaux J; Aprahamian M
    Br J Surg; 1999 Jul; 86(7):899-906. PubMed ID: 10417562
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Carotenoporphyrins as selective photodiagnostic agents for tumours.
    Reddi E; Segalla A; Jori G; Kerrigan PK; Liddell PA; Moore AL; Moore TA; Gust D
    Br J Cancer; 1994 Jan; 69(1):40-5. PubMed ID: 8286208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.